University of Münster
CRIS@UM
DE | EN

Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.

Pohlen M, Sargin B, Zicholl S, Bisping G, Müller-Tidow C, Berdel WE, Mesters R, Koschmieder S

Research article (journal)

Details about the publication

Journal: European Journal of Haematology (Eur J Haematol)
Volume: 84
Issue: 4
Page range: 362-364
Status: Published
Release year: 2009
Language in which the publication is written: English
Keywords: Humans; Receptors Fc; Autoantibodies; Immunologic Factors; Platelet Count; Recombinant Fusion Proteins; Antibodies Monoclonal; Thrombopoietin; Middle Aged; Adult; Drug Therapy Combination; Remission Induction; Purpura Thrombocytopenic Idiopathic; Female; Humans; Receptors Fc; Autoantibodies; Immunologic Factors; Platelet Count; Recombinant Fusion Proteins; Antibodies Monoclonal; Thrombopoietin; Middle Aged; Adult; Drug Therapy Combination; Remission Induction; Purpura Thrombocytopenic Idiopathic; Female

Authors from the University of Münster

Berdel, Wolfgang Eduard
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Bisping, Guido
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Koschmieder, Steffen
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Mesters, Rolf Michael
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Müller-Tidow, Carsten
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)